Status:

UNKNOWN

Clinical, Histological and Biochemical Characterization of Hyperpigmented Lesion

Lead Sponsor:

National University Hospital, Singapore

Conditions:

Lentigo

Melasma

Eligibility:

All Genders

21-80 years

Brief Summary

Hypothesis - The developments of solar lentigine and melasma are due to mutations in keratinocytes that drive the production and transfer of pigment from melanocytes to keratinocytes.

Detailed Description

Aims - 1. Characterize and classify lentigines and mealsma from a clinical and physiological point of view. This will help us to better understand the cellular processes leading to the development of...

Eligibility Criteria

Inclusion

  • Solar Lentigines and/or Melasma on facial, or neck areas
  • Ethnic background: Chinese, Malay, Indian, Caucasian
  • Age 21 - 80 years old
  • Ability to provide informed consent

Exclusion

  • Pregnant and lactating women
  • Children under the age of 20
  • Neoplasm (past or present) in excised area
  • Patients with communicable disease
  • Immuno-compromised patients
  • Current treatment with an investigational drug

Key Trial Info

Start Date :

June 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2015

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT01136629

Start Date

June 1 2008

End Date

May 1 2015

Last Update

January 28 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National University Hospital, Singapore

Singapore, Singapore, Singapore, 119074